Home
About
Overview
Sharing Data
ORCID
Help
History (18)
TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.
Trafficking and proteolytic processing of APP.
Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis.
A loss of function mutation in the COL9A2 gene causes autosomal recessive Stickler syndrome.
Post-remission therapy in acute myeloid leukemia: Are we ready for an individualized approach?
See All 18 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Post-remission therapy in acute myeloid leukemia: Are we ready for an individualized approach?
Post-remission therapy in acute myeloid leukemia: Are we ready for an individualized approach? Best Pract Res Clin Haematol. 2019 12; 32(4):101102.
View in:
PubMed
subject areas
Allografts
Cytarabine
Daunorubicin
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myeloid, Acute
Precision Medicine
Remission Induction
authors with profiles
Richard A. Larson
Benjamin Derman